CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for GENOMED SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

GENOMED SA
ul. Ponczowa 12
Phone: +48 226446019p:+48 226446019 Warszawa, 02-971  Poland Ticker: GENGEN
Business Summary
Genomed SA develops molecular diagnostics based on DNA sequencing in response to an ever greater demand for a service that enables the application of prophylactics and treatments such as replacement or gene therapy. The technology being developed by Genomed enables it to read and analyze any of the 6,500 discovered genes correlated with congenital diseases. The Company can boast genetic analyses of more than 150 genes responsible for such diseases, develops tools for the diagnostic analysis of the whole human exome and prepares the methodology necessary for the analysis of mutations in the whole human genome.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2022Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
3845 Electromedical and electrotherapeutic apparatus

General Information
Outstanding Shares: 1,321,301 (As of 12/31/2023)
Stock Exchange: WAR
Fax Number: +48 226446025


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024